Home > List All Publishers > La Merie Publishing

La Merie Publishing

La Merie Business Intelligence is focused on Research and Development in the Biopharmaceutical Industry. La Merie provides information about biopharmaceutical R&D and competitive intelligence by Publishing, Consultancy and its Biotech Portal PipelineReview.com. The information is retrieved from La Merie’s in house R&D database, news portal and direct as well as desktop searches. La Merie has a focus on Biologics, including antibodies, proteins, peptides, vaccines, RNA, DNA and cell therapy.

La Merie publishes Competitor Analysis Reports, Brief Reports and Full Reports. The Competitor Analysis Series delivers NO-FRILLS , but concise information about the pipeline of R&D projects for targets, diseases, technologies and companies.

The information is provided in a tabular format and fully referenced. Competitor analysis reports can be purchased as a la carte or obtained by subscribing to R&D Pipeline News. R&D Pipeline News is published weekly 50-times a year and each issue contains competitor evaluations. Individual products from the Competitor Analysis Series and R&D Pipeline News are elaborated by independent analysts of La Merie Business Intelligence. Brief Reports on Target Pipelines include assessment of the scientific as well as business perspective of new targets. Full reports provide in-depth analysis of product portfolios, R&D pipelines, competitive environment and a critical assessment of the pipeline perspective.

List of reports from La Merie Publishing

Competitor Analysis: Coagulation Factors 5/1/2013 \| published by: La Merie Publishing ... as of May 2013. Purchase of the pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent ... \| read more...	$800.00
Competitor Analysis: Thrombolytics & Fibrinolytics 5/1/2013 \| published by: La Merie Publishing ... for treatment of cardiovascular thrombosis, stroke and eye diseases. Purchase of the pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access ... \| read more...	$330.00
Competitor Analysis: Therapeutic Proteins – Biosimilars, Biobetters & Biosuperiors 5/1/2013 \| published by: La Merie Publishing ... and development pipelines of ten major classes of therapeutic proteins and their biosimilar and biobetter/biosuperior versions in regulated and less regulated markets: Erythropoiesis Stimulating Agents (ESA) G-CSF & GM-CSF Thrombopoietin & Thrombopoiesis Stimulating Agents Interferon ... \| read more...	$2,100.00
Competitor Analysis: G-CSF and GM-CSF 4/22/2013 \| published by: La Merie Publishing ... biosimilars (biogenerics, follow-on biologics) and next generation, longer acting products as of April 2013. Purchase of the pdf report includes a 6-month online access to the data of the report and any updates since the ... \| read more...	$522.00
Competitor Analysis: Thrombopoiesis Stimulating Agents (TPO and IL-11) 4/22/2013 \| published by: La Merie Publishing ... addition, the report lists company-specific R&D pipelines of Thrombopoiesis Stimulating Agents (TPO; IL-11). Purchase of the pdf report includes a 6-month online access to the data of the report and any updates since the publication ... \| read more...	$196.00
Competitor Analysis: Human Growth Hormone (hGH) 4/1/2013 \| published by: La Merie Publishing ... hormone deficiency (GHD) in childrens and adults and related diseases. 2012 global sales data of branded hGH products in regulated marktes are provided. Purchase of the downloadable pdf report includes a 6-month online access to ... \| read more...	$395.00
Competitor Analysis: Interferon 4/1/2013 \| published by: La Merie Publishing ... and of other subtypes for treatment of hepatitis B and C, other infectious diseases, cancer and multiple sclerosis, respectively. Purchase of the pdf report includes a 6-month online access to the data of the report ... \| read more...	$590.00
Competitor Analysis: Antibody-Drug Conjugates (ADC) 4/1/2013 \| published by: La Merie Publishing ... of April 2013. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent ... \| read more...	$785.00
Competitor Analysis: Erythropoiesis Stimulating Agents (ESA) 4/1/2013 \| published by: La Merie Publishing ... versions of erythropoietin (EPO) in regulated markets, a compilation of novel, next generation Erythropoiesis Stimulating Agents (ESAs) separately for biologics and for oral small molecules and a summary of first generation EPO products as well ... \| read more...	$650.00
Competitor Analysis: Insulin 4/1/2013 \| published by: La Merie Publishing ... 2 diabetes mellitus. Purchase of the pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by ... \| read more...	$590.00
Antibody Technologies and Attrition Rates – an industry analysis 2013 3/1/2013 \| published by: La Merie Publishing ... scientific and corporate publications as well as from patent and legal literature. The report provides descriptive statistics of the 504 naked antibodies and their status during the study period of January 1, 2013 to February ... \| read more...	$2,781.00
Competitor Analysis: FSH, hCG and LH - Therapeutic Proteins for Assisted Reproductive Technology (ART) 2/1/2013 \| published by: La Merie Publishing ... LH receptor agonists for treatment of infertility. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the ... \| read more...	$335.00
Competitor Analysis: Enzyme Replacement Therapies 1/1/2013 \| published by: La Merie Publishing ... genetic diseases/lysosomal storage diseases and exocrine pancreatic insufficiency due to cystic fibrosis, pancreatitis and other causes. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any ... \| read more...	$403.00
Competitor Analysis: Herpes Virus Vaccines and Therapeutics 12/1/2012 \| published by: La Merie Publishing ... (HSV) type 1 and/or type 2 and varicella zoster virus (VZV) or human herpes virus type 3 (HHV-3) as of December 2012. Purchase of the downloadable pdf report includes a 6-month online access to the ... \| read more...	$396.00
Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies 12/1/2012 \| published by: La Merie Publishing ... as biosimilar versions as of December 2012. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the ... \| read more...	$1,307.00
Competitor Analysis: EGF-R Antibodies –Biosimilars and Biosuperiors 12/1/2012 \| published by: La Merie Publishing ... Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and ... \| read more...	$261.00
Competitor Analysis: Toll-Like Receptor (TLR) Agonists & Antagonists 12/1/2012 \| published by: La Merie Publishing ... prevention of cancer, infectious diseases, sepsis and allergy as of December 2012. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication ... \| read more...	$910.00
Competitor Analysis: TNF Antibodies –Biosimilars and Biosuperiors 11/30/2012 \| published by: La Merie Publishing ... and autoimmune diseases as of November 2012. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the ... \| read more...	$523.00
Competitor Analysis: VEGF Antibodies – Bevacizumab and Ranibizumab Biosimilars and Biosuperiors 11/1/2012 \| published by: La Merie Publishing ... cancers and ophthalmic diseases as of November 2012. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access ... \| read more...	$392.00
Competitor Analysis: Her2 Antibodies - Trastuzumab Biosimilars and Biobetters/Biosuperiors 11/1/2012 \| published by: La Merie Publishing ... of November 2012. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent ... \| read more...	$392.00
Competitor Analysis: Pneumococcal and Streptococcal Vaccines 10/1/2012 \| published by: La Merie Publishing ... Streptococcus (GAS) or Group B Streptococcus (GBS) as of October 2012. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. ... \| read more...	$260.00
Competitor Analysis: CD20 Antibodies - Rituximab Biosimilars and Biobetters/Biosuperiors 10/1/2012 \| published by: La Merie Publishing ... arthritis as of October 2012. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will ... \| read more...	$390.00
Competitor Analysis: Interleukin-6 (IL-6) Inhibitors and IL-6 Receptor (IL-6R) Antagonists 10/1/2012 \| published by: La Merie Publishing ... Inhibitors and IL-6 Receptor (IL-6R) Antagonists as of October 2012. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials ... \| read more...	$195.00
Competitor Analysis: Tuberculosis Vaccines and Therapeutics 9/1/2012 \| published by: La Merie Publishing ... Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be sent by e-mail and ... \| read more...	$516.00
Competitor Analysis: CMV Vaccines and Therapeutics 8/1/2012 \| published by: La Merie Publishing ... as of August 2012. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be ... \| read more...	$247.00

< prev 1 2 3 4 5 6 7 next >